iodine and trypsinogen
iodine has been researched along with trypsinogen in 43 studies
Research
Studies (43)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (4.65) | 18.7374 |
1990's | 2 (4.65) | 18.2507 |
2000's | 18 (41.86) | 29.6817 |
2010's | 16 (37.21) | 24.3611 |
2020's | 5 (11.63) | 2.80 |
Authors
Authors | Studies |
---|---|
Abman, SH; Accurso, FJ; Hammond, KB; Sokol, RJ | 1 |
Black, A; Redmond, A; Roberts, G; Stanfield, M | 1 |
Blythe, SA; Farrell, PM | 1 |
Farrell, PM; Koscik, RE | 1 |
Gaskin, K; Massie, J; Van Asperen, P; Wilcken, B | 1 |
Castellani, C; Mastella, G; Tamanini, A | 1 |
Francis, I; Glazner, J; Massie, RJ; Olsen, M; Robertson, CF | 1 |
Cohn, JA; Jowell, PS; Knowles, MR; Noone, PG; Silverman, LM; Zhou, Z | 1 |
Bassotti, A; Corbetta, C; Padoan, R; Seia, M | 1 |
Bovo, P; Castellani, C; Cavallini, G; Gomez Lira, M; Mastella, G; Patuzzo, C; Pignatti, PF | 1 |
Ambrosioni, A; Bassotti, A; Corbetta, C; Giunta, A; Padoan, R; Seia, M | 1 |
Assael, BM; Belpinati, F; Bonamini, D; Castellani, C; Dechecchi, MC; Gomez-Lira, M; Patuzzo, C; Pignatti, PF; Sagramoso, C | 1 |
Farrell, PM; Hoffman, G; Laessig, RH; Lee, DS; Makholm, L; Peterson, A; Rosenberg, MA | 1 |
Clements, B; Massie, J | 1 |
Farrell, PM; Hoffman, G; Kopish, GJ; Laessig, RH; Litsheim, TJ; Rock, MJ | 1 |
Comeau, AM; Parad, RB | 1 |
Accurso, FJ; Hammond, KB; Sontag, MK; Wagener, JS; Zielenski, J | 1 |
Hayes, D | 1 |
Farrell, PM; Freeman, ME; Gershan, W; Koscik, RL; Lifchez, C; Modaff, P; Pfeil, D; Rock, MJ; Sullivan, B; Tluczek, A; Zaleski, C | 1 |
Accurso, FJ; Corey, M; Hokanson, JE; Marshall, JA; Sommer, SS; Sontag, MK; Zerbe, GO | 1 |
Kleven, DT; McCudden, CR; Willis, MS | 1 |
Comeau, AM; Dorkin, HL; Gerstle, R; Hale, JE; Lapey, A; O'Sullivan, BP; Parad, RB; Spencer, T; Yee, W | 1 |
Feneberg, R; Hoffmann, GF; Kohlmueller, D; Kulozik, AE; Leible, S; Lindner, M; Mall, MA; Muckenthaler, M; Sommerburg, O | 1 |
Desai, H; Dixon, M; Platt, M; Ren, CL | 1 |
Farrell, PM; Levy, H; Rock, MJ; Zaleski, C | 1 |
Farrell, PM; Lai, HJ; Rock, MJ; Sanders, DB | 1 |
Keiles, S; Kharrazi, M; Koepke, R; Parad, R | 1 |
Armstrong, DS; Curnow, L; Francis, I; Glazner, J; Massie, RJ | 1 |
Sontag, MK; Wagener, JS; Zemanick, ET | 1 |
Balaščaková, M; Chovancová, B; Dvořáková, L; Holubová, A; Kračmar, P; Křenková, P; Krulišová, V; Macek, M; Paděrová, J; Piskáčková, T; Skalická, V; Stambergová, A; Vávrová, V; Votava, F; Zemková, D | 1 |
Barben, J; Baumgartner, MR; Fingerhut, R; Gallati, S; Kuehni, CE; Rueegg, CS; Torresani, T | 1 |
Assael, BM; Castellani, C; Tamanini, A; Tridello, G | 1 |
Barben, J; Jurca, M; Kuehni, CE; Rueegg, CS; Spalinger, J | 1 |
Altieri, JP; Bergougnoux, A; Boureau-Wirth, A; Claustres, M; Koenig, M; Larrieu, L; Raynal, C; Rouzier, C; Verneau, F | 1 |
Audrézet, MP; Cheillan, D; Delmas, D; Lemonnier, L; Munck, A; Roussey, M | 1 |
Alcántara-Ortigoza, MA; Campos-Garcia, FJ; Contreras-Capetillo, SN; González Del Angel, A; Herrera-Pérez, LDA; Ibarra-González, I; León-Burgos, V; Maldonado-Solis, FA; Martínez-Cruz, P; Moreno-Graciano, CM; Vela-Amieva, M | 1 |
Lumertz, MS; Pinto, LA; Rispoli, T; Rosa, KMD | 1 |
Bellon, G; Bourmaud, A; Farrell, PM; Munck, A; Picq, P | 1 |
Course, CW; Doull, I; Forton, JT; Hanks, RE; Moat, SJ; Southern, KW; Thia, LP | 1 |
Arpin, J; Au, J; Bjornson, C; Brusky, J; Burgess, C; Chilvers, MA; Derynck, M; Donnelly, C; Dupuis, A; Fairservice, L; Gonska, T; Hammel, J; Henderson, N; Hughes, D; Iqbal, S; Itterman, J; Jober, A; Keenan, K; Kherani, T; Kosteniuk, L; Mateos-Corral, D; Morgan, L; Price, A; Ratjen, F; Reisman, J; Smith, MJ; Solomon, M; van Wylick, R | 1 |
Brewington, JJ; Ginsburg, DK; Saeed, MM; Salinas, DB; Wee, CP | 1 |
Alves Júnior, JV; Alvim, CG; Bedran, RM; Camargos, P; Nolasco, DM; Pereira, FH; Sader, OG; Zhang, L | 1 |
Colyer, CL; Yan, W | 1 |
Reviews
4 review(s) available for iodine and trypsinogen
Article | Year |
---|---|
Advances in the diagnosis and management of cystic fibrosis.
Topics: Adolescent; Anti-Bacterial Agents; Child; Child, Preschool; Chlorides; Cystic Fibrosis; Humans; Infant; Infant, Newborn; Mass Screening; Pancreatitis; Pilocarpine; Respiratory Tract Infections; Sweat; Trypsinogen | 1984 |
Diagnosis of cystic fibrosis after newborn screening: the Australasian experience--twenty years and five million babies later: a consensus statement from the Australasian Paediatric Respiratory Group.
Topics: Australasia; Australia; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Infant; Infant, Newborn; Neonatal Screening; New Zealand; Sweat; Trypsinogen | 2005 |
Cystic fibrosis: newborn screening in America.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Exocrine Pancreatic Insufficiency; Female; Genetic Testing; Humans; Infant, Newborn; Neonatal Screening; Pregnancy; Prenatal Diagnosis; Sodium Chloride; Sweat; Trypsinogen; United States; White People | 2008 |
Newborn screening for cystic fibrosis.
Topics: Biomarkers; Cystic Fibrosis; False Positive Reactions; Genetic Carrier Screening; Humans; Infant, Newborn; Neonatal Screening; Sweat; Trypsinogen | 2012 |
Trials
2 trial(s) available for iodine and trypsinogen
Article | Year |
---|---|
CFTR and cationic trypsinogen mutations in idiopathic pancreatitis and neonatal hypertrypsinemia.
Topics: Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Humans; Infant, Newborn; Infant, Newborn, Diseases; Mutation; Neonatal Screening; Pancreatitis; Pedigree; Phenotype; Polymorphism, Genetic; Sweat; Trypsin; Trypsinogen | 2001 |
Prospective and parallel assessments of cystic fibrosis newborn screening protocols in the Czech Republic: IRT/DNA/IRT versus IRT/PAP and IRT/PAP/DNA.
Topics: Antigens, Neoplasm; Biomarkers; Biomarkers, Tumor; Clinical Protocols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Czech Republic; DNA Mutational Analysis; Dried Blood Spot Testing; False Negative Reactions; False Positive Reactions; Genetic Markers; Humans; Infant, Newborn; Lectins, C-Type; Neonatal Screening; Pancreatitis-Associated Proteins; Prospective Studies; Sensitivity and Specificity; Sweat; Trypsinogen | 2012 |
Other Studies
37 other study(ies) available for iodine and trypsinogen
Article | Year |
---|---|
Efficacy of statewide neonatal screening for cystic fibrosis by assay of trypsinogen concentrations.
Topics: Clinical Protocols; Cystic Fibrosis; False Negative Reactions; False Positive Reactions; Humans; Incidence; Infant, Newborn; Neonatal Screening; Pilot Projects; Sweat; Trypsinogen | 1991 |
Screening for cystic fibrosis: a four year regional experience.
Topics: Age Factors; Child; Child, Preschool; Chlorides; Cystic Fibrosis; False Negative Reactions; False Positive Reactions; Family; Humans; Infant; Infant, Newborn; Mass Screening; Northern Ireland; Predictive Value of Tests; Radioimmunoassay; Sodium; Sweat; Time Factors; Trypsinogen | 1988 |
Sweat chloride concentrations in infants homozygous or heterozygous for F508 cystic fibrosis.
Topics: Age Factors; Alleles; Base Composition; Chlorides; Codon; Cystic Fibrosis; DNA; Follow-Up Studies; Gene Deletion; Genes, Regulator; Genotype; Heterozygote; Homozygote; Humans; Infant; Infant, Newborn; Iontophoresis; Mutation; Neonatal Screening; Parasympathomimetics; Pilocarpine; Sweat; Trypsinogen | 1996 |
Sweat testing following newborn screening for cystic fibrosis.
Topics: Chlorides; Cystic Fibrosis; Diagnosis, Differential; DNA Mutational Analysis; Female; Genetic Testing; Humans; Infant, Newborn; Male; Neonatal Screening; Retrospective Studies; Sensitivity and Specificity; Sodium; Sweat; Trypsinogen | 2000 |
Protracted neonatal hypertrypsinogenaemia, normal sweat chloride, and cystic fibrosis.
Topics: Adolescent; Chlorides; Cystic Fibrosis; Humans; Male; Neonatal Screening; Sputum; Sweat; Trypsinogen | 2000 |
Newborn screening for cystic fibrosis in Victoria: 10 years' experience (1989-1998).
Topics: Chlorides; Cystic Fibrosis; Humans; Neonatal Screening; Retrospective Studies; Sweat; Trypsinogen; Victoria | 2000 |
Cystic fibrosis gene mutations and pancreatitis risk: relation to epithelial ion transport and trypsin inhibitor gene mutations.
Topics: Adolescent; Adult; Alleles; alpha-Amylases; Child; Chlorides; Cystic Fibrosis; Epithelium; Female; Gene Frequency; Genetic Predisposition to Disease; Genotype; Humans; Ion Transport; Male; Middle Aged; Mutation; Pancreatitis; Plant Proteins; Polymorphism, Genetic; Sweat; Trypsin Inhibitors; Trypsinogen | 2001 |
Negative sweat test in hypertrypsinaemic infants with cystic fibrosis carrying rare CFTR mutations.
Topics: Child; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Infant; Infant, Newborn; Male; Mutation; Neonatal Screening; Sweat; Trypsin; Trypsinogen | 2002 |
Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Genetic Carrier Screening; Genetic Heterogeneity; Genotype; Humans; Infant, Newborn; Italy; Neonatal Screening; Pilot Projects; Prevalence; Program Evaluation; Sensitivity and Specificity; Sequence Deletion; Sweat; Trypsinogen | 2002 |
Cationic trypsinogen and pancreatic secretory trypsin inhibitor gene mutations in neonatal hypertrypsinaemia.
Topics: Carrier Proteins; Cations; Cystic Fibrosis Transmembrane Conductance Regulator; Genetic Predisposition to Disease; Growth Substances; Humans; Infant, Newborn; Intercellular Signaling Peptides and Proteins; Italy; Mutation; Neonatal Screening; Polymorphism, Genetic; Sweat; Trypsin; Trypsin Inhibitor, Kazal Pancreatic; Trypsinogen | 2003 |
Analysis of the costs of diagnosing cystic fibrosis with a newborn screening program.
Topics: Chlorides; Cost Savings; Cystic Fibrosis; Health Care Costs; Humans; Infant, Newborn; Monte Carlo Method; Neonatal Screening; Sweat; Trypsinogen; Wisconsin | 2003 |
Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
Topics: Age Factors; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Early Diagnosis; Electrophoresis, Polyacrylamide Gel; Fluoroimmunoassay; Heterozygote; Homozygote; Humans; Incidence; Infant; Infant, Newborn; Iontophoresis; Muscarinic Agonists; Neonatal Screening; Pilocarpine; Polymerase Chain Reaction; Randomized Controlled Trials as Topic; Sensitivity and Specificity; Sweat; Trypsinogen; Wisconsin | 2005 |
Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
Topics: Algorithms; Chlorides; Clinical Protocols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Decision Trees; DNA Mutational Analysis; False Negative Reactions; False Positive Reactions; Follow-Up Studies; Humans; Immunoassay; Infant, Newborn; Massachusetts; Mutation; Neonatal Screening; Practice Guidelines as Topic; Sweat; Trypsinogen | 2005 |
Two-tiered immunoreactive trypsinogen-based newborn screening for cystic fibrosis in Colorado: screening efficacy and diagnostic outcomes.
Topics: Chlorides; Colorado; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; False Negative Reactions; Fluoroimmunoassay; Genotype; Humans; Incidence; Infant, Newborn; Mandatory Testing; Mutation; Neonatal Screening; Predictive Value of Tests; Radioimmunoassay; Sensitivity and Specificity; Severity of Illness Index; Sweat; Trypsinogen | 2005 |
Newborn screening for cystic fibrosis.
Topics: Chlorides; Cystic Fibrosis; DNA Mutational Analysis; Genetic Testing; Humans; Infant, Newborn; Neonatal Screening; Sweat; Trypsinogen; United States | 2006 |
Newborn screening for cystic fibrosis: parents' preferences regarding counseling at the time of infants' sweat test.
Topics: Adaptation, Psychological; Adolescent; Adult; Choice Behavior; Consumer Behavior; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Female; Follow-Up Studies; Genetic Carrier Screening; Genetic Counseling; Health Education; Humans; Infant; Infant, Newborn; Male; Middle Aged; Neonatal Screening; Parents; Referral and Consultation; Social Support; Sweat; Trypsinogen | 2006 |
Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
Topics: Biomarkers; Body Height; Body Weight; Chlorides; Cystic Fibrosis; DNA Mutational Analysis; Fats; Feces; Female; Follow-Up Studies; Genetic Predisposition to Disease; Genotype; Humans; Ileus; Infant, Newborn; Longitudinal Studies; Malabsorption Syndromes; Male; Neonatal Screening; Predictive Value of Tests; Severity of Illness Index; Sweat; Trypsinogen; Vitamins | 2006 |
Cystic fibrosis newborn screening: using experience to optimize the screening algorithm.
Topics: Algorithms; Biomarkers; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Genetic Testing; Humans; Immunoassay; Infant, Newborn; Massachusetts; Mutation; Neonatal Screening; Predictive Value of Tests; Primary Health Care; Program Development; Program Evaluation; Quality Indicators, Health Care; Retrospective Studies; Sweat; Trypsinogen | 2010 |
Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.
Topics: Antigens, Neoplasm; Biomarkers; Biomarkers, Tumor; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Enzyme-Linked Immunosorbent Assay; Genetic Testing; Germany; Humans; Infant, Newborn; Lectins, C-Type; Mutation; Neonatal Screening; Pancreatitis-Associated Proteins; Predictive Value of Tests; Program Evaluation; Prospective Studies; Sensitivity and Specificity; Sweat; Trypsinogen | 2010 |
Clinical outcomes in infants with cystic fibrosis transmembrane conductance regulator (CFTR) related metabolic syndrome.
Topics: Anti-Bacterial Agents; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Feces; Female; Hospitalization; Humans; Infant; Infant, Newborn; Male; Metabolic Syndrome; Monitoring, Physiologic; Neonatal Screening; Oropharynx; Pancreatic Elastase; Pseudomonas aeruginosa; Pseudomonas Infections; Respiratory Tract Infections; Retrospective Studies; Sweat; Trypsinogen | 2011 |
Factors accounting for a missed diagnosis of cystic fibrosis after newborn screening.
Topics: Chlorides; Cystic Fibrosis; Diagnostic Errors; Female; Humans; Infant; Infant, Newborn; Male; Neonatal Screening; Sensitivity and Specificity; Sweat; Trypsinogen | 2011 |
Comparing age of cystic fibrosis diagnosis and treatment initiation after newborn screening with two common strategies.
Topics: Cystic Fibrosis; DNA Mutational Analysis; Genetic Carrier Screening; Genotyping Techniques; Humans; Infant; Infant, Newborn; Neonatal Screening; Sweat; Trypsinogen | 2012 |
Impact of IVS8-(TG)m(T)n on IRT and sweat chloride levels in newborns identified by California CF newborn screening.
Topics: California; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA; DNA Mutational Analysis; Female; Genotype; Humans; Incidence; Infant; Infant, Newborn; Male; Mutation; Neonatal Screening; Sweat; Trypsinogen | 2012 |
Lessons learned from 20 years of newborn screening for cystic fibrosis.
Topics: Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA; DNA Mutational Analysis; Female; Follow-Up Studies; Genetic Testing; Humans; Infant, Newborn; Male; Mutation; Neonatal Screening; Pregnancy; Prevalence; Prognosis; Retrospective Studies; Sweat; Time Factors; Trypsinogen; Victoria | 2012 |
Newborn screening for cystic fibrosis in Switzerland--consequences after analysis of a 4 months pilot study.
Topics: Algorithms; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; DNA Mutational Analysis; Humans; Infant, Newborn; Neonatal Screening; Pilot Projects; Sensitivity and Specificity; Sweat; Switzerland; Trypsinogen | 2013 |
Sweat chloride and immunoreactive trypsinogen in infants carrying two
Topics: Child; Child, Preschool; Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Infant; Mutation; Sweat; Trypsinogen | 2017 |
Measurement of fecal elastase improves performance of newborn screening for cystic fibrosis.
Topics: Algorithms; Clinical Protocols; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Early Diagnosis; Early Medical Intervention; Genetic Testing; Humans; Infant, Newborn; Neonatal Screening; Pancreatic Elastase; Prognosis; Quality Improvement; Sweat; Switzerland; Time Factors; Trypsinogen | 2016 |
A false positive newborn screening result due to a complex allele carrying two frequent CF-causing variants.
Topics: Alleles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnosis, Differential; False Positive Reactions; Family; Female; Genetic Testing; Genetic Variation; Humans; Immunologic Tests; Infant, Newborn; Medical History Taking; Neonatal Screening; Sweat; Trypsinogen | 2016 |
Optimization of the French cystic fibrosis newborn screening programme by a centralized tracking process.
Topics: Algorithms; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; France; Humans; Infant; Infant, Newborn; Male; Mutation; Neonatal Screening; Retrospective Studies; Sensitivity and Specificity; Sweat; Time Factors; Trypsinogen | 2018 |
Newborn cystic fibrosis screening in southeastern Mexico: Birth prevalence and novel CFTR gene variants.
Topics: Alleles; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Humans; Infant, Newborn; Male; Mexico; Mutation; Neonatal Screening; Prevalence; Reproducibility of Results; Sweat; Trypsinogen | 2018 |
False-negative newborn screening result for immunoreactive trypsinogen: a major problem in children with chronic lung disease.
Topics: Child; Chronic Disease; False Negative Reactions; Humans; Infant, Newborn; Lung Diseases; Neonatal Screening; Sweat; Trypsinogen | 2019 |
Phenotype of children with inconclusive cystic fibrosis diagnosis after newborn screening.
Topics: Child; Chlorides; Cohort Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Genotype; Hospitalization; Humans; Infant, Newborn; Male; Metabolic Diseases; Methicillin-Resistant Staphylococcus aureus; Neonatal Screening; Phenotype; Prognosis; Pseudomonas aeruginosa; Sweat; Trypsinogen | 2020 |
Cystic fibrosis newborn screening: the importance of bloodspot sample quality.
Topics: Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Dried Blood Spot Testing; False Negative Reactions; Humans; Incidence; Infant; Infant, Newborn; Meconium Ileus; Neonatal Screening; Predictive Value of Tests; Retrospective Studies; Selection Bias; Sweat; Trypsinogen; Wales | 2021 |
Outcomes of Cystic Fibrosis Screening-Positive Infants With Inconclusive Diagnosis at School Age.
Topics: Age Factors; Biomarkers; Canada; Child; Chlorides; Cohort Studies; Confidence Intervals; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Female; Genetic Variation; Genotype; Humans; Infant, Newborn; Longitudinal Studies; Male; Neonatal Screening; Nutritional Status; Pancreatic Function Tests; Prospective Studies; Reference Values; Respiratory Function Tests; Sweat; Trypsinogen | 2021 |
Gradual increase in sweat chloride concentration is associated with a higher risk of CRMS/CFSPID to CF reclassification.
Topics: Child; Chlorides; Cross-Sectional Studies; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Humans; Infant; Infant, Newborn; Neonatal Screening; Retrospective Studies; Sweat; Trypsinogen | 2023 |
Sweat conductivity for diagnosing cystic fibrosis after positive newborn screening: prospective, diagnostic test accuracy study.
Topics: Chlorides; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Diagnostic Tests, Routine; Humans; Infant; Infant, Newborn; Neonatal Screening; Prospective Studies; Sweat; Trypsinogen | 2023 |
Fluorimetric studies and noncovalent labeling of protein with the near-infrared dye HITCI for analysis by CE-LIF.
Topics: Animals; Buffers; Carbocyanines; Cattle; Coloring Agents; Drug Stability; Electrophoresis, Capillary; Humans; Hydrogen-Ion Concentration; Iodides; Lasers; Proteins; Serum Albumin; Serum Albumin, Bovine; Solvents; Spectrometry, Fluorescence; Spectroscopy, Near-Infrared; Trypsinogen; Water | 2005 |